1. Opening remarks

   • Gerd Heusch

   EditorialNotes Pages: 867 - 867

2. Pharmacological aspects of calcium channel blockers

   • Hasso Scholz

   OriginalPaper Pages: 869 - 872

3. Nisoldipine CC: Efficacy and tolerability in hypertension and ischemic heart disease

   • J. George Fodor

   OriginalPaper Pages: 873 - 879

4. DEFIANT-II: A study of nisoldipine CC after myocardial infarction

   • Richard Hall

   BriefCommunication Pages: 881 - 881

5. Calcium channel blockers and hypertension: Evolving perspectives—1996

   • Murray Epstein

   OriginalPaper Pages: 883 - 891

6. Calcium channel blockers: Summary and safety issues

   • Lionel H. Opie

   BriefCommunication Pages: 893 - 895